Features and Outcomes of Children with Ulcerative Colitis who Undergo a Diagnostic Change: A Single-Center Experience
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: A change in diagnosis from ulcerative colitis (UC) to Crohn's disease (CD) has been reported in pediatric inflammatory bowel disease; however, only a few clinical characteristics and predictors of this diagnostic change have been reported. We aimed to describe the clinical characteristics of patients with UC who underwent a change in diagnosis to CD and identify variables associated with the change. Methods: The medical records of pediatric patients with UC who were followed up at the National Center for Child Health and Development between 2006 and 2019 were retrospectively reviewed. Clinical data on disease phenotype, laboratory parameters, endoscopic findings, and treatment of patients whose diagnosis changed to CD (cCD) were compared to those of patients whose diagnosis remained UC (rUC). Results: Among the 111 patients initially diagnosed with UC, 11 (9.9%) patients were subsequently diagnosed with CD during follow-up. There was no significant difference between the cCD and rUC groups in terms of sex, age at initial diagnosis, and the extent and severity of disease at initial diagnosis. Albumin and hemoglobin levels were significantly lower in the cCD group than in the rUC group. The proportion of patients who required biologics was significantly higher in the cCD group than in the rUC group (p<0.05). Conclusion: Approximately 10% children initially diagnosed with UC were subsequently diagnosed with CD. Hypoalbuminemia and anemia at initial diagnosis and use of biologics could be predictors of this diagnostic change.
Abstract
Purpose: A change in diagnosis from ulcerative colitis (UC) to Crohn's disease (CD) has been reported in pediatric inflammatory bowel disease; however, only a few clinical characteristics and predictors of this diagnostic change have been reported. We aimed to describe the clinical characteristics of patients with UC who underwent a change in diagnosis to CD and identify variables associated with the change. Methods: The medical records of pediatric patients with UC who were followed up at the National Center for Child Health and Development between 2006 and 2019 were retrospectively reviewed. Clinical data on disease phenotype, laboratory parameters, endoscopic findings, and treatment of patients whose diagnosis changed to CD (cCD) were compared to those of patients whose diagnosis remained UC (rUC). Results: Among the 111 patients initially diagnosed with UC, 11 (9.9%) patients were subsequently diagnosed with CD during follow-up. There was no significant difference between the cCD and rUC groups in terms of sex, age at initial diagnosis, and the extent and severity of disease at initial diagnosis. Albumin and hemoglobin levels were significantly lower in the cCD group than in the rUC group. The proportion of patients who required biologics was significantly higher in the cCD group than in the rUC group (p<0.05). Conclusion: Approximately 10% children initially diagnosed with UC were subsequently diagnosed with CD. Hypoalbuminemia and anemia at initial diagnosis and use of biologics could be predictors of this diagnostic change.
참고문헌 (39)
- Ungaro R, "Ulcerative colitis", Lancet, 389, pp.1756~1770 (2017)
- Torres J, "Crohn's disease", Lancet, 389, pp.1741~1755 (2017)
- Størdal K, "Pediatric inflammatory bowel disease in southeastern Norway : a five-year follow-up study", Digestion, 70, pp.226~230 (2004)
- Carvalho RS, "Indeterminate colitis : a significant subgroup of pediatric IBD", Inflamm Bowel Dis, 12, pp.258~262 (2006)
- Van Limbergen J, "Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease", Gastroenterology, 135, pp.1114~1122 (2008)
- Romano C, "Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children", Pediatrics, 122, pp.e1278~e1281 (2008)
- Prenzel F, "Frequency of indeterminate colitis in children and adults with IBD-a metaanalysis", J Crohn's Colitis, 3, pp.277~281 (2009)
- Abraham BP, "Natural history of pediatric-onset inflammatory bowel disease : a systematic review", J Clin Gastroenterol, 46, pp.581~589 (2012)
- Winter DA, "Pediatric IBD-unclassified is less common than previously reported; results of an 8-year audit of the EUROKIDS registry", Inflamm Bowel Dis, 21, pp.2145~2153 (2015)
- Müller KE, "Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 57, pp.576~582 (2013)
- Malaty HM, "The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood : within a 25 year period", Clin Exp Gastroenterol, 6, pp.115~121 (2013)
- Rinawi F, "The natural history of pediatric-onset IBD-unclassified and prediction of Crohn's disease reclassification : a 27-year study", Scand J Gastroenterol, 52, pp.558~563 (2017)
- Levine A, "ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents", J Pediatr Gastroenterol Nutr, 58, pp.795~806 (2014)
- Joossens S, "The value of serologic markers in indeterminate colitis : a prospective follow-up study", Gastroenterology, 122, pp.1242~1247 (2002)
- Mamula P, "Inflammatory bowel disease in children 5 years of age and younger", Am J Gastroenterol, 97, pp.2005~2010 (2002)
- Alexander F, "Fate of the pouch in 151 pediatric patients after ileal pouch anal anastomosis", J Pediatr Surg, 38, pp.78~82 (2003)
- Levine A, "Pediatric modification of the Montreal classification for inflammatory bowel disease : the Paris classification", Inflamm Bowel Dis, 17, pp.1314~1321 (2011)
- Turner D, "Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study", Gastroenterology, 133, pp.423~432 (2007)
- Turner D, "Mathematical weighting of the pediatric Crohn's disease activity index(PCDAI)and comparison with its other short versions", Inflamm Bowel Dis, 18, pp.55~62 (2012)
- Kanda Y, "Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics", Bone Marrow Transplant, 48, pp.452~458 (2013)
- Cleynen I, "Inherited determinants of Crohn's disease and ulcerative colitis phenotypes : a genetic association study", Lancet, 387, pp.156~167 (2016)
- Subramanian S, "Recent advances in clinical practice: a systematic review of isolated colonic Crohn's disease: the third IBD?", Gut, 66, pp.362~381 (2017)
- Birimberg-Schwartz L, "Development and validation of diagnostic criteria for IBD subtypes including IBD-unclassified in children : a multicentre study from the Pediatric IBD Porto Group of ESPGHAN", J Crohn's Colitis, 11, pp.1078~1084 (2017)
- Turner D, "Management of paediatric ulcerative colitis, part 1: ambulatory care-an evidence-based guideline from European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition", J Pediatr Gastroenterol Nutr, 67, pp.257~291 (2018)
- Ledder O, "Appraisal of the PIBD-classes criteria : a multicenter validation", J Crohn's Colitis, 14, pp.1672~1679 (2020)
- Triester SL, "A meta-analysis of the yield of capsule endoscopy compared to other diagnostic modalities in patients with non-stricturing small bowel Crohn's disease", Am J Gastroenterol, 101, pp.954~964 (2006)
- Cohen SA, "Capsule endoscopy may reclassify pediatric inflammatory bowel disease : a historical analysis", J Pediatr Gastroenterol Nutr, 47, pp.31~36 (2008)
- Greer MC, "Paediatric magnetic resonance enterography in inflammatory bowel disease", Eur J Radiol, 102, pp.129~137 (2018)
- Feagan BG, "Ustekinumab as induction and maintenance therapy for Crohn's disease", N Engl J Med, 375, pp.1946~1960 (2016)
- Sandborn WJ, "Vedolizumab as induction and maintenance therapy for Crohn's disease", N Engl J Med, 369, pp.711~721 (2013)
- Feagan BG, "Vedolizumab as induction and maintenance therapy for ulcerative colitis", N Engl J Med, 369, pp.699~710 (2013)
- Sandborn WJ, "Tofacitinib as induction and maintenance therapy for ulcerative colitis", N Engl J Med, 376, pp.1723~1736 (2017)
- Melmed GY, "Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study", Clin Gastroenterol Hepatol, 5, pp.602~608 (2007)
- Jakobsen C, "Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease--a population-based study", Aliment Pharmacol Ther, 34, pp.1217~1224 (2011)
- Yu H, "Market share and costs of biologic therapies for inflammatory bowel disease in the USA", Aliment Pharmacol Ther, 47, pp.364~370 (2018)
- Weinstein TA, "Age and family history at presentation of pediatric inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 37, pp.609~613 (2003)
- Tsampalieros A, "Use of C-reactive protein in children with newly diagnosed inflammatory bowel disease", J Pediatr, 159, pp.340~342 (2011)
- Mack DR, "Laboratory values for children with newly diagnosed inflammatory bowel disease", Pediatrics, 119, pp.1113~1119 (2007)
- Takaki Y, "Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease", Pediatr Int, 61, pp.720~725 (2019)